Sodium Valproate Inquiry Officially Begins
The inquiry into the historical licensing and prescribing of Sodium Valproate (Epilim) in Ireland has officially begun its work.
The inquiry into the historical licensing and prescribing of Sodium Valproate (Epilim) in Ireland has officially begun its work.
We are delighted to be inviting research proposals as part of our 9th Research funding call – which will be run in conjunction with the Health Research Charities/Health Research Board (HRCI/HRB Joint Funding Scheme).
As part of the continuing efforts to reduce the risks associated with the anti-seizure medication, Sodium Valproate (Epilim), the Health Products Regulatory Authority (HPRA) have recently reissued patient information materials and reminders to prescribers and pharmacists about their obligations under the Pregnancy Prevention Programme (PPP) and risk reduction measures associated with the medication.
We are delighted to share the news that the My Moving Brain series which has been led by our colleagues in FutureNeuro, has been shortlisted for a Chambers Ireland Sustainable Business Impact Award.
We have commenced the hiring process for the position of Communications Officer.
Working with our Advocacy & Communications Manager, this position will directly contribute to the advancement of our Strategic Plan, with a particular focus on the key aim of increasing the visibility of epilepsy and Epilepsy Ireland.
Can you help researchers from the University of Galway by sharing your experience?
Researchers from Maynooth University are inviting adults in Ireland with epilepsy to take part in a new study exploring the timing and storage of daily anti-seizure medication (ASMs). The study, called TimeAlign, is investigating whether the time of day and the regularity that people with epilepsy take their medication affects their seizure control.
We are looking forward to meeting with the Department of Health over the coming weeks to discuss one of our key advocacy campaigns.
June 23rd is Dravet Syndrome Awareness Day.
We've begun planning for International Epilepsy Day 2026 and would like your feedback!